Description
MIRATIME-S Tablets are a combination therapy designed for the management of overactive bladder (OAB) in adults, particularly in patients experiencing urgency, frequency, and urge incontinence. This formulation combines Mirabegron ER, a β3-adrenergic receptor agonist, and Solifenacin Succinate, a muscarinic receptor antagonist, providing dual-action relief from bladder overactivity.
-
Mirabegron ER 50 mg: Relaxes the detrusor muscle during the storage phase of the bladder cycle, increasing bladder capacity and reducing urinary frequency.
-
Solifenacin Succinate 5 mg: Reduces involuntary bladder contractions by blocking muscarinic M3 receptors, thereby controlling urgency and urge incontinence.
Benefits of MIRATIME-S Tablets
-
Enhances bladder storage function
-
Reduces urinary urgency and frequency
-
Controls urge incontinence
-
Convenient once-daily dosing
